Iranian Blood transfusion organization has implemented a mandatory haemovigilance system to monitor Adverse Transfusion Events (ATEs) since 2009.
The scope of Iranian Haemovigilance System (IHS) encompasses all blood components issued by blood transfusion centers, all adverse reactions and all hospitals (public and private hospitals).
After preparing the standard forms, slides, different guidelines and SOPs, all health care staff including nurses and doctors as well as the staff of hospital blood banks have been trained to identify and manage all adverse reactions of blood transfusion. From January 2009 to 2016, this system was established in 612 (73%) hospitals (from 863 hospitals across the country). Hospitals use uniform forms for blood requests; monitor patients during blood administration and report all adverse reactions.
We aimed to gather and analyze transfusion reactions to help prevent their occurrence and/or reoccurrence.
- EMRO with the collaboration of IBTO and IRETM published The First Regional Status Report on Blood Safety and Availability
- IRETM and universities of Kurdistan regional government to collaborate on academic and educational areas
- Re-designation of IBTO as WHO Collaborating Center for 2017-2021
- Visit of IBTO Managing Director to Afghanistan Blood Service
- Three days international workshop on GMP in Blood Transfusion
- For the first time, blood transfusion on emergency helicopter saved the lives of wounded
- Tehran-Hanoi cycling tour in commemoration of World Blood Donor Day
- Opening Ceremony of Joint IRETM-UPEC Diploma Course on Management of Blood Transfusion Medicine
- Iranian Minister of Health: IBTO stands in the way of progress
- Training of Trainers workshop on Good Manufacturing Practices in blood transfusion